Edition:
United Kingdom

PAVmed Inc (PAVM.OQ)

PAVM.OQ on NASDAQ Stock Exchange Capital Market

1.85USD
19 Jan 2018
Change (% chg)

$-0.69 (-27.17%)
Prev Close
$2.54
Open
$1.82
Day's High
$1.85
Day's Low
$1.77
Volume
149,302
Avg. Vol
6,271
52-wk High
$9.25
52-wk Low
$1.77

Select another date:

Thu, Jan 18 2018

BRIEF-PAVmed Announces Firm Commitment Public Offering Of Common Stock

* PAVMED ANNOUNCES FIRM COMMITMENT PUBLIC OFFERING OF COMMON STOCK Source text for Eikon: Further company coverage:

BRIEF-Pavmed Initiates Reduction In Exercise Price Of Series W Warrants

* PAVMED INITIATES REDUCTION IN EXERCISE PRICE OF SERIES W WARRANTS Source text for Eikon: Further company coverage:

BRIEF-Pavmed Files 510(K) Submission With Fda For Carpx Device To Treat Carpal Tunnel Syndrome

* PAVMED FILES 510(K) SUBMISSION WITH FDA FOR CARPX™ DEVICE TO TREAT CARPAL TUNNEL SYNDROME

BRIEF-Pavmed reports Q3 adjusted non-GAAP loss per share $0.13

* Q3 adjusted non-GAAP loss per share $0.13 Source text for Eikon: Further company coverage:

BRIEF-Pavmed offers up to 2.7 mln shares

* Pavmed files for offering of up to 2.7 million shares of co that may be offered for resale by selling stockholders - SEC filing Source text: http://bit.ly/2iDN6XW Further company coverage:

BRIEF-Pavmed says has received a letter from FDA regarding its portio intraosseous infusion system​

* Pavmed Inc - has received a letter from food and drug administration regarding its portio intraosseous infusion system​

BRIEF-PAVmed files for mixed shelf of up to $75 million

* PAVmed files for mixed shelf of up to $75 million - SEC filing Source text: (http://bit.ly/2hkAgwR) Further company coverage:

BRIEF-Pavmed CEO Lishan Aklog buys 9,100 shares of co's common stock

* Pavmed Inc CEO ‍lishan Aklog reports purchase of 9,100 shares of co's common stock between Aug 23-24 - SEC filing ​ Source text: (http://bit.ly/2vdLcGE) Further company coverage:

Select another date: